Survey of pharmacist collaborative drug therapy management in hospitals

Thomas, Joseph; Bharmal, Murtuza; Lin, Shu-Wen; Punekar, Yogesh Suresh

doi:10.2146/ajhp050205

Cited by 23 publications

(18 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2003, 49.7% of pharmacists in the United States performed their pharmaceutical activities according to the Collaborative Drug Therapy Management (CDTM) in hospitals. 25 The CDTM has been frequently The efficacy of our PBPM in warfarin therapy in this study is consistent with the results of CDTM, which has previously been documented. [5][6][7][8][9][10] However, in most of these previous reports, the aims of warfarin therapies were focused on the treatment of AF.…”

Section: Discussionsupporting

confidence: 90%

Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 90%

Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery

et al. 2017

View full text Add to dashboard Cite

show abstract

“…For example, some states may allow initiation of medication therapy (independent prescribing) and others may only allow modification of existing drug therapy (dependent prescribing). 24 An organization must comply with the Pharmacy Practice Act of the state in which it resides when developing a CPA; individual states may also include educational prerequisites, allowable drug classes, quality assurance, and documentation requirements in their regulations that govern use of CPAs.…”

Section: Cpa Definitionmentioning

confidence: 99%

Utilization of Collaborative Practice Agreements between Physicians and Pharmacists as a Mechanism to Increase Capacity to Care for Hematopoietic Stem Cell Transplant Recipients

Merten

Shapiro

Gulbis

et al. 2013

Biology of Blood and Marrow Transplantation

View full text Add to dashboard Cite

Survival following hematopoietic stem cell transplantation (HSCT) has improved and the number of allogeneic HSCTs performed annually in the United States is expected to reach 10,000 by 2015. The National Marrow Donor Program created the System Capacity Initiative to formulate mechanisms to care for the growing number of HSCT recipients. One proposed method to increase capacity is utilization of pharmacists to manage drug therapy via collaborative practice agreements (CPAs). Pharmacists have managed drug therapy in oncology patients with CPAs for decades; however, there are limited HSCT centers that employ this practice. Engaging in collaborative practice and billing agreements with credentialed pharmacists to manage therapeutic drug monitoring, chronic medical conditions and supportive care in HSCT recipients may be cost-effective and enable physicians to spend more time on new or more complex patients. The goal of this paper is to provide a framework for implementation of a CPA and address how it may improve HSCT program capacity.

show abstract

“…These results were particularly surprising because a previously published survey concluded that CDTM was used at about 50% of hospitals in the United States, not distinguishing between adult hospitals and children's hospitals. 7 It appears that CDTM occurs less often in the care of children, regardless of the type of children's hospital. Therefore, some adult hospitals may limit the CDTM to adult patients only and not provide it for their pediatric patients.…”

Section: Discussionmentioning

confidence: 99%

“…6 Some surveys have attempted to determine this information. 7,8 Among those surveys was one conducted in 1996, which included results obtained from 713 hospital pharmacy directors. 7 This study found that 56% of hospital pharmacists participated in some form of CDTM at their institution.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Survey Evaluating the Practice of Children's Hospitals Having Pharmacist Collaborative Drug Therapy Management Protocols

Welsh

Miah

Girotto

2016

The Journal of Pediatric Pharmacology and Therapeutics

View full text Add to dashboard Cite

OBJECTIVES: The purpose of this study is to determine how frequently children's hospitals in the United States are using pharmacist-physician collaborative drug therapy management (CDTM), and to characterize their use in this population. METHODS: A phone survey was created to collect data regarding the use of pharmacist-physician CDTM at children's hospitals. Children's hospitals were called between February 2014 and April 2014. Data were collected from either a clinical pharmacist or pharmacy director. Pharmacists were asked to answer questions regarding hospital demographics as well as to what extent and for which medications they use CDTM. Differences between types of hospitals were evaluated using Fisher exact test. RESULTS: A total of 171 children's hospitals were identified; 51.5% hospitals (n = 88) completed the survey. Of the 88 hospitals that completed the survey, 32 (31.7%) had some level of CDTM in place. Of the 28 children's hospitals with CDTM in place that completed the survey, all allowed pharmacists to modify doses and monitor therapy, and 75% provided pharmacists with the ability to initiate the first dose. The specific medications that were included in the CDTM protocols in children's hospitals included vancomycin (n = 23), aminoglycosides (n = 22), anticoagulation medications (n = 7), and total parenteral nutrition (n = 3). Training was required for pharmacists to participate in CDTM protocols at most hospitals (n = 26). Lack of support from medical staff was the most common perceived barrier. No differences were identified between types of children's hospitals. CONCLUSION: CDTM protocols are practiced in about one third of the children's hospitals. Pharmacists commonly initiate, monitor, and modify therapies as part of these protocols. The most frequently included medications were vancomycin and aminoglycosides.

show abstract

Survey of pharmacist collaborative drug therapy management in hospitals

Cited by 23 publications

References 15 publications

Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery

Efficacy of protocol-based pharmacotherapy management on anticoagulation with warfarin for patients with cardiovascular surgery

Utilization of Collaborative Practice Agreements between Physicians and Pharmacists as a Mechanism to Increase Capacity to Care for Hematopoietic Stem Cell Transplant Recipients

Survey Evaluating the Practice of Children's Hospitals Having Pharmacist Collaborative Drug Therapy Management Protocols

Contact Info

Product

Resources

About